USD 0.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 27.4 Million USD | 51.75% |
2018 | 18.05 Million USD | -30.77% |
2017 | 26.08 Million USD | 43025.16% |
2016 | 60.48 Thousand USD | 1.96% |
2015 | 59.31 Thousand USD | -0.12% |
2014 | 59.38 Thousand USD | 0.73% |
2013 | 58.96 Thousand USD | 4.04% |
2012 | 56.67 Thousand USD | -2.56% |
2011 | 58.16 Thousand USD | 2.63% |
2010 | 56.67 Thousand USD | 1.31% |
2009 | 55.93 Thousand USD | 11.24% |
2008 | 50.28 Thousand USD | 107.4% |
2007 | 24.24 Thousand USD | 468.04% |
2006 | 4268.00 USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 Q3 | 3.47 Million USD | 244.69% |
2020 Q2 | 1 Million USD | -15.05% |
2020 FY | - USD | -100.0% |
2020 Q1 | 1.18 Million USD | -18.2% |
2019 FY | 27.4 Million USD | 51.75% |
2019 Q4 | 1.44 Million USD | -92.36% |
2019 Q3 | 18.96 Million USD | 737.03% |
2019 Q2 | 2.26 Million USD | -52.04% |
2019 Q1 | 4.72 Million USD | 33.48% |
2018 Q4 | 3.53 Million USD | 61.0% |
2018 Q2 | 1.65 Million USD | -80.53% |
2018 Q1 | 8.51 Million USD | -61.54% |
2018 FY | 18.05 Million USD | -30.77% |
2018 Q3 | 2.19 Million USD | 32.69% |
2017 Q3 | 659.44 Thousand USD | -80.0% |
2017 FY | 26.08 Million USD | 43025.16% |
2017 Q1 | 17.06 Thousand USD | 15.16% |
2017 Q4 | 22.12 Million USD | 3255.3% |
2017 Q2 | 3.29 Million USD | 19226.04% |
2016 FY | 60.48 Thousand USD | 1.96% |
2016 Q3 | 13.83 Thousand USD | -6.09% |
2016 Q4 | 14.81 Thousand USD | 7.08% |
2016 Q2 | 14.73 Thousand USD | -13.82% |
2016 Q1 | 17.09 Thousand USD | 16.63% |
2015 Q3 | 13.9 Thousand USD | 0.48% |
2015 FY | 59.31 Thousand USD | -0.12% |
2015 Q4 | 14.65 Thousand USD | 5.41% |
2015 Q2 | 13.84 Thousand USD | -18.17% |
2015 Q1 | 16.91 Thousand USD | 18.47% |
2014 FY | 59.38 Thousand USD | 0.73% |
2014 Q4 | 14.27 Thousand USD | 3.22% |
2014 Q1 | 16.73 Thousand USD | 21.7% |
2014 Q3 | 13.83 Thousand USD | -4.93% |
2014 Q2 | 14.54 Thousand USD | -13.08% |
2013 Q4 | 13.75 Thousand USD | -0.58% |
2013 Q3 | 13.83 Thousand USD | 1.3% |
2013 Q2 | 13.65 Thousand USD | -22.96% |
2013 Q1 | 17.72 Thousand USD | 36.94% |
2013 FY | 58.96 Thousand USD | 4.04% |
2012 Q3 | 15.53 Thousand USD | 36.55% |
2012 Q4 | 12.94 Thousand USD | -16.69% |
2012 Q1 | 16.82 Thousand USD | 13.5% |
2012 Q2 | 11.37 Thousand USD | -32.36% |
2012 FY | 56.67 Thousand USD | -2.56% |
2011 Q2 | 12.7 Thousand USD | -30.22% |
2011 Q3 | 12.42 Thousand USD | -2.27% |
2011 Q4 | 14.82 Thousand USD | 19.32% |
2011 FY | 58.16 Thousand USD | 2.63% |
2011 Q1 | 18.21 Thousand USD | 40.22% |
2010 Q1 | 18.63 Thousand USD | 51.82% |
2010 Q3 | 12.58 Thousand USD | 1.07% |
2010 Q4 | 12.98 Thousand USD | 3.19% |
2010 FY | 56.67 Thousand USD | 1.31% |
2010 Q2 | 12.45 Thousand USD | -33.17% |
2009 Q4 | 12.27 Thousand USD | -7.87% |
2009 Q2 | 12.9 Thousand USD | -25.96% |
2009 Q1 | 17.43 Thousand USD | 5.34% |
2009 FY | 55.93 Thousand USD | 11.24% |
2009 Q3 | 13.32 Thousand USD | 3.25% |
2008 Q4 | 16.54 Thousand USD | 22.97% |
2008 FY | 50.28 Thousand USD | 107.4% |
2008 Q1 | 11.48 Thousand USD | 76.16% |
2008 Q2 | 8796.00 USD | -23.41% |
2008 Q3 | 13.45 Thousand USD | 52.98% |
2007 Q2 | 6339.00 USD | 13.12% |
2007 FY | 24.24 Thousand USD | 468.04% |
2007 Q1 | 5604.00 USD | 0.0% |
2007 Q3 | 5782.00 USD | -8.79% |
2007 Q4 | 6519.00 USD | 12.75% |
2006 FY | 4268.00 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Bright Green Corporation | 8.25 Million USD | 100.0% |
BioQuest Corp. | 89.76 USD | 100.0% |
Clever Leaves Holdings Inc. | 21.16 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 9.73 Million USD | 100.0% |
High Sierra Technologies, Inc. | 238.36 Thousand USD | 100.0% |
Instadose Pharma Corp. | - USD | NaN% |